Doctor profile · Federal record

Dr. Ashwini Vaidya, MD

Dermatology Physician (CMS: Dermatology) · Procedural Dermatology Physician · Tulsa, OK

  • NPI 1063495380
  • Accepts Medicare
  • MIPS 90.8 / 100 · 2023
  • 27 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2121 E 21St St
Tulsa, OK 741141409
(918) 749-2261
fax (918) 749-8712
Mailing address
Po Box 52588
Tulsa, OK 741520588

Credentials & registration

NPPES · NUCC
NPI registered
November 2005 — 21 yrs on file
Profile last updated
October 11, 2012
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Oklahoma #23219
Medicaid
OK #100749090B

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1063495380. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,834
Distinct HCPCS
10
Medicare allowed
$236,576
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 2,093 385 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 893 659 $85
17000 Destruction of precancer skin growth, 1 growth 708 523 $50
17110 Destruction of skin growth, 1-14 growths 263 230 $103
11102 Biopsy of related skin growth, first growth 250 203 $84
99214 Established patient office or other outpatient visit, 30-39 minutes 241 197 $121
99203 New patient office or other outpatient visit, 30-44 minutes 68 68 $105
99212 Established patient office or other outpatient visit, 10-19 minutes 60 58 $53
11103 Biopsy of related skin growth, each additional growth 50 35 $46
17111 Destruction of skin growth, 15 or more growths 50 39 $121

In context: peer comparison

Among 10 peers in Tulsa Dermatology Physician, average services per provider: 240. This provider delivers 20× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,351
Transactions
124
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 22 $443.30
Janssen Biotech, INC. 13 $225.27
Regeneron Healthcare Solutions, INC. 8 $195.75
Amgen INC. 7 $190.98
Novartis Pharmaceuticals Corporation 10 $190.18
Lilly USA, LLC 11 $172.01
E.R. Squibb & Sons, L.L.C. 11 $160.42
Incyte Corporation 11 $157.22
Arcutis Biotherapeutics, INC. 12 $145.91
Ortho Dermatologics, A Division of Bausch Health US, LLC 4 $76.39
Galderma Laboratories, L.P. 5 $73.76
Leo Pharma INC. 3 $67.05
Verrica Pharmaceuticals INC. 3 $63.11
Sun Pharmaceutical Industries INC. 2 $44.91
Mayne Pharma Commercial LLC 2 $38.85

By nature of payment

Food and Beverage
$2,351

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
759
Patients
396
Total drug cost
$29,061
Drug Type Claims Patients Total cost
Finasteride Generic 141 37 $1,479
Triamcinolone Acetonide Generic 104 77 $1,096
Clobetasol Propionate Generic 90 49 $8,980
Hydrocortisone Generic 72 51 $479
Fluorouracil Generic 60 57 $5,715
Minocycline Hcl Generic 43 13 $924
Nystatin Generic 42 25 $707
Ketoconazole Generic 36 20 $920
Doxycycline Hyclate Generic 32 0 $1,015
Betamethasone Dipropionate Generic 31 21 $1,630

Frequently asked questions

Auto-generated from federal data
What is Dr. Ashwini Vaidya's medical specialty?
Dr. Ashwini Vaidya practices Dermatology Physician in Tulsa, OK.
Where does Dr. Ashwini Vaidya practice?
Dr. Ashwini Vaidya practices at 2121 E 21St St, Tulsa, OK 741141409. Office phone: 9187492261.
What is Dr. Ashwini Vaidya's NPI?
Dr. Ashwini Vaidya's National Provider Identifier (NPI) is 1063495380, issued by NPPES.
Does Dr. Ashwini Vaidya accept Medicare assignment?
Yes. Dr. Ashwini Vaidya accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ashwini Vaidya commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.